Development of potent dual BET/HDAC inhibitors via pharmacophore merging and structure-guided optimization https://www.biorxiv.org/content/10.1101/2023.07.18.547334v1?med=mas
Development of potent dual BET/HDAC inhibitors via pharmacophore merging and structure-guided optimization https://www.biorxiv.org/content/10.1101/2023.07.18.547334v1?med=mas